Tomi Airenne

Title: Tomi Airenne: Innovator in Vascular Adhesion Protein Research

Introduction

Tomi Airenne is a notable inventor based in Turku, Finland. He has made significant contributions to the field of vascular adhesion proteins, particularly through his innovative research and patenting activities. His work focuses on the structural information of crystalline human VAP-1, which has important implications for medical research and drug development.

Latest Patents

Tomi Airenne holds a patent for "Crystalline VAP-1 and uses thereof." This invention relates to crystalline vascular adhesion protein-1 (VAP-1) and outlines methods for utilizing structural information of crystalline human VAP-1 for the identification, design, and production of ligands and inhibitors. The patent also includes screening assays for the detection of these compounds, as well as inhibitors identified through these assays. He has 1 patent to his name.

Career Highlights

Tomi Airenne is associated with Biotie Therapies Corporation, where he applies his expertise in vascular adhesion proteins. His work at the company has contributed to advancements in understanding and treating various medical conditions related to vascular adhesion.

Collaborations

Tomi collaborates with talented professionals in his field, including Tiina Annamaria Salminen and Mark Stuart Johnson. Their combined efforts enhance the research and development initiatives at Biotie Therapies Corporation.

Conclusion

Tomi Airenne is a distinguished inventor whose work on crystalline VAP-1 has the potential to impact medical research significantly. His contributions to the field of vascular adhesion proteins demonstrate the importance of innovation in advancing healthcare solutions.